The latest quarterly earnings report for Illumina, Inc. is scheduled for Wednesday, April 29th. Analysts estimate an earnings per share (EPS) of $1.06.
Illumina, Inc. (ILMN) is currently priced at $126.81, experiencing a decrease of $1.71 (-1.33%) from the previous close of $128.52. The trading volume stands at $317,063, representing a 17.11% increase compared to the average volume.
The most recent quarterly earnings for Illumina, Inc. were reported on Wednesday, February 4th, with a consensus EPS estimate of 1.2. Further revenue details are pending.
In summary, Illumina, Inc. is gearing up for its upcoming earnings release with analysts closely monitoring the EPS estimate. The current trading session sees a slight decrease in the stock price, accompanied by above-average trading volume. Key financial ratios reflect a stable financial position for the company.
This financial report provides a snapshot of Illumina, Inc.'s current status and upcoming financial events.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.